NASDAQ · SHFSW

SHF Holdings, Inc.

$0.03 +$0.00 (+5.08%) 1D

Key Metrics

$117.10K
Market cap
P/E · TTM
$7.72M
Revenue · TTM
−$3.11M
Net income
EPS · TTM $-0.72
Dividend yield
Free cash flow
Beta · 1Y 1.89
EBITDA · TTM −$5.17M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 18
    From its Jan 29 high, the share price fell 45%.

    Peak close $0.04 on Jan 29; trough close $0.02 on Jun 18. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -45%
  • Jun 18
    The stock moved -24.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 18
  • Apr 30
    The stock moved -19.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 30

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap
Enterprise value
Shares outstanding
52-wk range$0.02 – $0.06
Avg volume · 20D38.6K
Net cash
Book value / share$1.54
IndustryFinance Services
ExchangeNASDAQ
About SHF Holdings, Inc.
IPO dateSep 29, 2022
Employees40

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.02
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating -67.0%
Net -40.3%
FCF
ROE / ROIC -46.3% · —

Financial Health

Current ratio1.81
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$5.53M

Cash Flow · TTM

Operating CF −$3.36M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

-11.3
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings